Disease Pattern, Risk factors of Antimicrobial Resistance in Patients with Pneumococcal Infection in Hong Kong Population

  06 November 2025

This ten-year study (2012–2021) from Hong Kong examined antimicrobial resistance (AMR) in pneumococcal disease (PD) caused by Streptococcus pneumoniae. The overall incidence of PD remained stable until it sharply declined in 2020 due to the COVID-19 pandemic. Alarmingly, 80% of isolates were resistant to at least one antibiotic, with high non-susceptibility to tetracyclines (85%) and macrolides (79%), and moderate resistance to penicillins (23%). Nearly half of typed infections were caused by serotype 3 — a strain still prevalent despite the introduction of the PCV13 vaccine in 2011. AMR was particularly common among non-invasive PD cases in children and adolescents (ages 2–17). The findings highlight the ongoing threat of serotype 3 and antibiotic resistance in S. pneumoniae, emphasizing the need for targeted prevention and treatment strategies for school-age populations.

Author(s): Jack Chi-him Lau et al
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!